1. Home
  2. IOVA vs LFST Comparison

IOVA vs LFST Comparison

Compare IOVA & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • LFST
  • Stock Information
  • Founded
  • IOVA 2007
  • LFST 2015
  • Country
  • IOVA United States
  • LFST United States
  • Employees
  • IOVA N/A
  • LFST N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • LFST Medical/Nursing Services
  • Sector
  • IOVA Health Care
  • LFST Health Care
  • Exchange
  • IOVA Nasdaq
  • LFST Nasdaq
  • Market Cap
  • IOVA 771.4M
  • LFST 1.9B
  • IPO Year
  • IOVA N/A
  • LFST 2021
  • Fundamental
  • Price
  • IOVA $1.88
  • LFST $4.51
  • Analyst Decision
  • IOVA Buy
  • LFST Strong Buy
  • Analyst Count
  • IOVA 10
  • LFST 5
  • Target Price
  • IOVA $12.22
  • LFST $8.50
  • AVG Volume (30 Days)
  • IOVA 10.4M
  • LFST 2.4M
  • Earning Date
  • IOVA 08-07-2025
  • LFST 08-07-2025
  • Dividend Yield
  • IOVA N/A
  • LFST N/A
  • EPS Growth
  • IOVA N/A
  • LFST N/A
  • EPS
  • IOVA N/A
  • LFST N/A
  • Revenue
  • IOVA $212,679,000.00
  • LFST $1,283,503,000.00
  • Revenue This Year
  • IOVA $86.62
  • LFST $15.27
  • Revenue Next Year
  • IOVA $69.95
  • LFST $13.94
  • P/E Ratio
  • IOVA N/A
  • LFST N/A
  • Revenue Growth
  • IOVA 11070.12
  • LFST 16.31
  • 52 Week Low
  • IOVA $1.64
  • LFST $4.48
  • 52 Week High
  • IOVA $12.51
  • LFST $8.61
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 47.47
  • LFST 27.78
  • Support Level
  • IOVA $1.68
  • LFST $4.61
  • Resistance Level
  • IOVA $2.02
  • LFST $4.88
  • Average True Range (ATR)
  • IOVA 0.11
  • LFST 0.20
  • MACD
  • IOVA 0.03
  • LFST -0.01
  • Stochastic Oscillator
  • IOVA 61.42
  • LFST 4.46

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.

Share on Social Networks: